"Chemokine CXCL1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CXC chemokine with specificity for CXCR2 RECEPTORS. It has growth factor activities and is implicated as a oncogenic factor in several tumor types.
| Descriptor ID |
D054360
|
| MeSH Number(s) |
D12.644.276.374.200.120.050 D12.776.467.374.200.120.050 D12.776.624.664.700.049 D23.125.300.120.050 D23.469.200.120.050 D23.529.374.200.120.050
|
| Concept/Terms |
Chemokine CXCL1- Chemokine CXCL1
- CXCL1, Chemokine
- CXCL1 Chemokine
- Chemokine, CXCL1
- Gro-alpha Protein
- Gro alpha Protein
- GROalpha Protein
- Melanoma Growth Stimulatory Activity, alpha Protein
- MGSA-alpha Chemokine
- Chemokine, MGSA-alpha
- MGSA alpha Chemokine
- Neutrophil-Activating Protein 3
- Neutrophil Activating Protein 3
- Chemokine (C-X-C Motif) Ligand 1
- Growth-Related Oncogene alpha Protein
- Growth Related Oncogene alpha Protein
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CXCL1".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CXCL1".
This graph shows the total number of publications written about "Chemokine CXCL1" by people in this website by year, and whether "Chemokine CXCL1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CXCL1" by people in Profiles.
-
Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression. J Affect Disord. 2019 Apr 15; 249:410-417.
-
Reduced Corneal Innervation in the CD25 Null Model of Sj?gren Syndrome. Int J Mol Sci. 2018 Nov 30; 19(12).
-
Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study. Lancet Gastroenterol Hepatol. 2018 10; 3(10):698-707.
-
Thrombocytosis as a prognostic factor in inflammatory breast cancer. Breast Cancer Res Treat. 2017 Dec; 166(3):819-832.
-
MyD88 contribution to ocular surface homeostasis. PLoS One. 2017; 12(8):e0182153.
-
Human monocytes accelerate proliferation and blunt differentiation of preadipocytes in association with suppression of C/EBP? mRNA. Obesity (Silver Spring). 2012 Feb; 20(2):253-62.
-
CCL20, ?d T cells, and IL-22 in corneal epithelial healing. FASEB J. 2011 Aug; 25(8):2659-68.
-
Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses. Clin Cancer Res. 2010 Nov 15; 16(22):5458-68.
-
Interferon-? attenuates lung inflammation following experimental subarachnoid hemorrhage. Crit Care. 2010; 14(4):R157.
-
A chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response. Infect Immun. 2008 Mar; 76(3):978-85.